Paper Diagnostics Market

Paper Diagnostics Market 2022 - By Product Outlook, By Device Type Outlook, By Application Outlook, By End-use Outlook & Global Region - Market Size, Trends, Opportunity, Historical Review and Forecast 2027

Request Sample Request Discount
  • Status : Upcoming
  • Published on: July 2022
  • Report ID: KDMI-6978
  • Available Format: PDF/Excel/DOC


Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Paper Diagnostics Market

Request Sample

In 2021, the global paper diagnostics market was valued at USD 5.9 billion and is poised to witness a growth rate of 8.1% during forecast period. Due to the increased need for cost-effective healthcare in remote areas of developing countries, there is growing popularity of point-of-care diagnostic methods in these countries. Increased adoption of point-of-care diabetes test kits and pregnancy test kits is projected to favor the paper diagnostics market in developed countries.

Market Insights

Changing lifestyle habits such as smoking and unhealthy diet combined with increased incidence of obesity is anticipated to increase the prevalence of lifestyle-related disorders such as diabetes and cardiac diseases across the globe. This will lead to the development of diabetic paper diagnostic test kits in the near future, thereby driving the market. Furthermore, increased investments by the government in Research and Development related to the development of the novel in vitro diagnostics tests and devices have been thrust to the paper diagnostics market. Every year, the European Diagnostics Manufacturers Association (EDMA) invests approximately 1 billion euros in R&D of in vitro diagnostics. With the increased incidence of hospital-acquired urinary tract diseases in India and urging hospitals, doctors focus on delivering proper care and inclusion of diagnostic techniques. There is an urgent need to develop new systems and replacements, including up-grading medical infrastructure. These are also projected to influence the market positively. Moreover, there are untapped opportunities in emerging economies such as India, China, and Brazil in the field of point care diagnostics and it is also expected to boost the market.

The lateral flow assays segment accounted for more than 55% of the market's largest revenue share. The growth is due to the vast usage rate of pregnancy tests and a wide range of product-type applications. Moreover, there is a growing incidence of infectious diseases such as HIV, TB, and pneumonia, which is expected to increase the paper diagnostics market's growth. For instance, in the year 2016, there were around 2.8 million cases of TB in India. Moreover, India accounted for a quarter of the global TB cases. Also, government and healthcare organizations' efforts to create awareness about the detection and treatment of TB contribute to the growth of the paper diagnostics market. The paper-based microfluidics segment has significant growth due to the surging demand for point of care testing and Research and Development investments by life sciences and pharmaceutical organizations. For example, a self-powered, paper-based electrochemical device was developed to identify diseases such as anemia. It is a device made out of paper and helps detect biomarkers and identify diseases by performing an electrochemical analysis. The diagnostic devices market accounted the leading share of revenue in 2017. In blood separation and glucose detection, paper diagnostic devices are used. Greater flexibility and adaptability can be provided by Novel wax patterning technology, thereby increasing the diagnostics devices segment's potential. The monitoring devices also witness a healthy growth. This is due to the increased use of devices in the application, including food testing and nutrient monitoring in aquatic systems. Government bodies will also support the growth of the paper diagnostics market.

Segmentation Analysis

Based on Product, the market is segmented into lateral flow assays, dipsticks and paper-based microfluidics. Lateral flow assays segment captured a significant portion of market in 2021. This can be attributed to large scale application in disease diagnostics.

By application, the market is further analysed into clinical diagnostics, food quality testing and environmental monitoring. Clinical diagnostics segment is expected to witness substantial growth during the forecast period.

Key market players

The key market players are:

  • ARKRAY, Inc.
  • ACON Laboratories, Inc.
  • Abbott
  • Bio-Rad Laboratories, Inc.
  • GVS S.p.A.
  • Siemens Healthcare GmbH
  • Diagnostics for All, Inc.
  • FFEI; Navigene
  • Micro Essential Laboratory Inc
  • MedLife
  • Kenosha Tapes
  • Abcam plc
  • Abingdon Health
  • ACON Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • NanoHybrids
  • Merck KGaA
  • Surmodics, Inc.
  • Expedeon Ltd.

Market Segmentation

Product Outlook 

  • Lateral Flow Assays
  • Dipsticks
  • Paper Based Microfluidics

Device Type Outlook 

  • Diagnostic Devices
  • Monitoring Devices

Application Outlook  

  • Clinical Diagnostics
    • Cancer
    • Infectious diseases
    • Liver Disorders
    • Other
  • Food Quality Testing
  • Environmental Monitoring

End-use Outlook  

  • Home Healthcare
  • Assisted Living Healthcare Facilities
  • Hospital and Clinics

Regional Outlook  

  • North America (The U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, Poland, Turkey, Switzerland, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, South Korea, Vietnam, Philippines, Malaysia, Indonesia, Thailand, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Columbia, Argentina, Chile, and Rest of Latin America)
  • Middle East & Africa (South Africa, Saudi Arabia, UAE, Oman, Egypt, and Rest of Middle East & Africa)

Powered by Froala Editor

Powered by Froala Editor

Custom Research Requirement? Questions to ask?

Get in touch

Custom Research requirement.

Go Up